Dr. Edith Perez Discusses Anti-HER2 Therapies -- 2012 SABCS

preview_player
Показать описание

The live broadcast was sponsored by Genomic Health, the creator of Oncotype DX. Genomic Health is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions. For more information, please visit:
  1. Breast Cancer Answers®
  2. breast cancer
  3. SABCS
  4. breast cancer conference
  5. medical interview
  6. Genomic Health
Рекомендации по теме
Dr. Edith Perez 0:16:17

Dr. Edith Perez Discusses Anti-HER2 Therapies -- 2012 SABCS

Dr. Edith Perez 0:01:20

Dr. Edith Perez on the Etirinotecan Pegol for HER2-Negative Breast Cancer

Immune Function Marker 0:04:20

Immune Function Marker Does Not Predict Benefit of Trastuzumab in HER+ Breast Cancer Patients

ALTTO Trials Findings 0:04:26

ALTTO Trials Findings For Treating HER2+ Breast Cancer - Mayo Clinic

The Estrogen-Receptor Antagonist 0:06:37

The Estrogen-Receptor Antagonist Fulvestrant in Breast Cancer

HER2 Metastatic Breast 0:04:28

HER2 Metastatic Breast Cancer Treatment

Anti-HER2 strategies in 0:02:37

Anti-HER2 strategies in breast cancer: the ALTTO trial

Management of patients 0:20:39

Management of patients after adjuvant Truztuzumab and pertuzumab

Breast Cancer Index 0:13:04

Breast Cancer Index (BCI)

Are New Breast 0:01:25

Are New Breast Cancer Treatment Options Always The Best?

Frontline T-DM1 in 0:03:58

Frontline T-DM1 in HER2-Positive Metastatic Breast Cancer

Next-generation antibody-drug conjugates 0:02:11

Next-generation antibody-drug conjugates in HER2+ breast cancer

Pertuzumab as personalized 0:03:57

Pertuzumab as personalized therapy for breast cancer - Video abstract 37100

Benefit of Antibody 0:01:55

Benefit of Antibody Drug Conjugate T-DM1 in HER2+ BC

What is the 0:01:19

What is the prognosis and predictive information for lymph node negative patients?

Cancer - Sherri 0:05:43

Cancer - Sherri S. Gendelman Fund for Ovarian Cancer Research

Expert Perspectives: Breast 0:21:15

Expert Perspectives: Breast Cancer

Targeted Breast Cancer 0:08:41

Targeted Breast Cancer Therapies

Optimizing CDK4/6 Inhibition 0:03:04

Optimizing CDK4/6 Inhibition in HR+ Breast Cancer

Study: Adding Targeted 0:01:54

Study: Adding Targeted Therapy to Standard Treatment Helps Women Live Longer with Breast Cancer

ASCO 2013 - 0:05:42

ASCO 2013 - Elizabeth A. Mittendorf, M.D., Ph.D., HER2 Peptide Vaccine

PD-1 therapy with 0:03:26

PD-1 therapy with eribulin for triple negative MBC

Paclitaxel With Pertuzumab 0:04:34

Paclitaxel With Pertuzumab Plus Trastuzumab in Metastatic Breast Cancer

When is the 0:01:20

When is the appropriate time to order the Oncotype DX test?

welcome to shbcf.ru